Standards Coordinating Body For Gene Cell & Regenerative Medicines
Baltimore, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1340 Smith Ave #200, Baltimore, MD 21209, USA
- Website
- standardscoordinatingbody.org
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Financials
- Diversified Financials
- Capital Markets
- Fundraising
- SIC code
- 83 Social Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $115,472 |
| FY2023 | $267,240 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Standards development for regenerative medicine therapies | National Institute of Standards and Technology | $1,091,420 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Develop and implement undergraduate or graduate level curriculum, or a continuing education training for the existing… | National Institute of Standards and Technology | $500,000 |
Similar vendors
About the company
Standards Coordinating Body For Gene Cell & Regenerative Medicines is a non-profit, tax-exempt corporate entity registered in SAM.gov that specializes in standards development and educational initiatives within the regenerative medicine sector. The organization focuses on creating and implementing standards, educational curricula, and training programs related to advanced medical technologies, particularly in the domains of gene, cell, and regenerative medicine. Registered since August 2017 with current SAM.gov registration valid through July 2025, the organization has established itself as a critical facilitator of technical standards and workforce development in emerging medical technology domains.
Through federal contract awards, the organization has primarily engaged with the National Institute of Standards and Technology (NIST) on standards development projects. Specifically, the entity was awarded a $2,214,773 firm fixed-price purchase order for developing standards for regenerative medicine therapies, with a contract completion date of May 2, 2026. The contract was a non-set-aside award, indicating open competitive procurement, and directly supports NIST's objective of advancing measurement tools and standards in regenerative medicine. The contract represents a targeted effort to create technical frameworks and standardization protocols for emerging regenerative medical technologies.
In terms of federal grant awards, Standards Coordinating Body For Gene Cell & Regenerative Medicines has secured a $500,000 cooperative agreement from NIST to develop comprehensive educational and training initiatives. The grant focuses on creating undergraduate and graduate-level curriculum and continuing education programs centered on regenerative medicine standards. The project involves developing asynchronous online courses through the Standards Education Institute, including optional hands-on training opportunities that will provide ANSI-accredited stackable credentials. The grant aims to distribute course materials domestically and internationally, partnering with institutions like Montgomery College and the University of New Hampshire, and engaging with the International Society for Cell & Gene Therapy to broaden the reach and impact of regenerative medicine standards education.
Quick answers
Is Standards Coordinating Body For Gene Cell & Regenerative Medicines registered in SAM.gov?
Yes. Standards Coordinating Body For Gene Cell & Regenerative Medicines's SAM.gov registration is active through June 15, 2027.
What is Standards Coordinating Body For Gene Cell & Regenerative Medicines's CAGE code?
Standards Coordinating Body For Gene Cell & Regenerative Medicines's CAGE code is 7XY82, and its Unique Entity ID (UEI) is D71MRJJYCVZ4.
How much has Standards Coordinating Body For Gene Cell & Regenerative Medicines received in federal contracts?
Federal contracts obligated $382,712 to Standards Coordinating Body For Gene Cell & Regenerative Medicines in fiscal years 2023 through 2027.
What is Standards Coordinating Body For Gene Cell & Regenerative Medicines's most recent federal award?
Standards Coordinating Body For Gene Cell & Regenerative Medicines's most recent federal grant award is Develop and implement undergraduate or graduate level curriculum, or a continuing education training for the existing… (70NANB24H099), from National Institute of Standards and Technology, on October 1, 2024.
On GovTribe
See Standards Coordinating Body For Gene Cell & Regenerative Medicines's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors